PC
ORGO icon

PA Capital’s Organogenesis Holdings ORGO Stock Holding History

PA Capital’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$171K Buy
44,485
+9,714
+28% +$38.4K 0.12% 161
2020
Q2 		$134K Sell
34,771
-10,242
-23% -$36.9K 0.1% 155
2020
Q1 		$145K Buy
45,013
+6,810
+18% +$29.1K 0.13% 148
2019
Q4 		$184K Buy
+38,203
New +$242K 0.16% 115

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PA Capital's ORGO Position: Q3 2020 in Review

PA Capital increased its Organogenesis Holdings (ORGO) stake by 28% in Q3 2020, buying an estimated $38.4K and bringing the position to 44,485 shares worth $171K. The position accounts for 0.12% of the portfolio, ranked #161.

PA Capital first reported a position in ORGO in Q4 2019 and has held it in 4 quarters since. The position peaked at $184K in Q4 2019. 50 funds tracked by Wall St. Rank hold ORGO as of Q3 2020.

  • PA Capital held 44,485 shares of Organogenesis Holdings worth $171K as of Q3 2020.
  • PA Capital bought 9,714 Organogenesis Holdings shares in Q3 2020, an estimated $38.4K.
  • Organogenesis Holdings made up 0.12% of PA Capital's portfolio in Q3 2020, its #161 holding.
  • PA Capital first reported a position in Organogenesis Holdings in Q4 2019 and has held it in 4 quarters since.
  • PA Capital's Organogenesis Holdings position peaked at $184K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.